Efficacy of agomelatine on sleep disorders and lateral habenula neuronal activity in chronic restraint stress depression model mice
Authors:
- 9 September 2024
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 242 (2) , 353-360
Abstract
Background Sleep disorders (SD) are one of the common manifestations of depression patients. This article aimed to explore the effect of Agomelatine (Ago) on SD in chronic restraint stress (CRS) depression model mice and its effect on the activity of neurons in the lateral habenula (LHb). Methods 30 C57BL/6 J mice were divided into normal (C57BL/6 J) group, CRS group, and Ago group. CRS experiment was used to establish the depression model, and Ago was used to treat CRS mice. Based on behavioral tests in mice and electrophysiology record, SD and LHb neuron activity were assessed. The expression levels of brain-derived neurotrophic factor (BDNF) and nuclear phosphoprotein (c-Fos) in LHb were detected by Western blot (WB). Results As against the CRS group, the Ago group had a reduction in the immobility time during forced swimming training and an increase in the preference for sucrose in the sucrose preference test; The expression levels of c-Fos and BDNF proteins in the LHb neurons of the Ago group mice were lower than those in the CRS group (P < 0.05), and the values approached the levels of the normal control group. In both dark and light environments, the rapid eye movement (REM) sleep duration of the CRS group mice was significantly longer than that of the normal control group (P < 0.05). Conclusion It was concluded that Ago may intervene in the depressive-like behavior and overall sleep patterns of CRS depression model mice by regulating the activity of LHb neurons and inhibiting the neuroinflammatory process. This provides a potential drug target for the development of new treatment strategies for depression.Keywords
This publication has 23 references indexed in Scilit:
- Effect of sleep deprivation by MMP-WM on rat neurological function and Tau protein in hippocampusCellular and Molecular Biology, 2023
- The relationship between sleep disturbance and cognitive impairment in mood disorders: A systematic reviewJournal of Affective Disorders, 2023
- Brain-derived neurotrophic factor (BDNF) in perinatal depression: Side show or pivotal factor?Drug Discovery Today, 2022
- Efficacy of repetitive transcranial magnetic stimulation and agomelatine on sleep quality and biomarkers of adult patients with mild to moderate depressive disorderJournal of Affective Disorders, 2022
- Efficacy of agomelatine with cognitive behavioral therapy for delayed sleep-wake phase disorder in young adults: A randomized controlled studyBehavioral Sleep Medicine, 2022
- Rapid Eye Movement Sleep Behavior Disorder in Parkinson’s Disease: A Survey-Based StudyCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2022
- Reward ameliorates depressive-like behaviors via inhibition of the substantia innominata to the lateral habenula projectionScience Advances, 2022
- The global prevalence of major depressive disorder (MDD) among the elderly: A systematic review and meta-analysisNeuroscience & Biobehavioral Reviews, 2022
- Correlations with REM sleep behavior disorder severity in isolated rapid eye movement sleep behavior disorders patientsInternational Journal of Neuroscience, 2021
- Global prevalence of depression and elevated depressive symptoms among adolescents: A systematic review and meta‐analysisBritish Journal of Clinical Psychology, 2021